Frequency and Longitudinal Course of Motor Signs in Genetic Frontotemporal Dementia
Metadata
Show full item recordAuthor
Schönecker, Sonja; Martínez Murcia, Francisco Jesús; Gorriz Sáez, Juan Manuel; Genetic Frontotemporal Dementia InitiativeEditorial
Lippincot Williams & Wilkins
Date
2022-09-06Referencia bibliográfica
Schönecker, S... [et al.] (2022). Frequency and longitudinal course of motor signs in genetic frontotemporal dementia. Neurology, 99(10), e1032-e1044. doi:[10.1212/WNL.0000000000200828]
Sponsorship
UK Research & Innovation (UKRI) Medical Research Council UK (MRC) MR/M023664/1; German Research Foundation (DFG) EXC 2145 390857198; Ministry of Health, Italy; Canadian Institutes of Health Research (CIHR); JPND grant GENFIprox; European Reference Network for Rare Neurological Diseases (ERN-RND) European Commission European Commission Joint Research Centre ERNRND: 3HP 767231; Ministerio de Ciencia e Innovacion (Espana)/FEDER RTI2018-098913-B100; Junta de Andalucia; European Commission CV20-45250 A-TIC080-UGR18; Canadian Institutes of Health Research (CIHR) MOP 327387; Weston Brain Institute; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); European Commission SUAG/051 G101400; National Institute for Health Research (NIHR) BRC-1215-20014Abstract
Background and Objectives
Frontotemporal dementia (FTD) is a highly heritable disorder. The majority of genetic cases
are caused by autosomal dominant pathogenic variants in the chromosome 9 open reading
frame 72 (c9orf72), progranulin (GRN), and microtubule-associated protein tau (MAPT) gene.
As motor disorders are increasingly recognized as part of the clinical spectrum, the current
study aimed to describe motor phenotypes caused by genetic FTD, quantify their temporal
association, and investigate their regional association with brain atrophy.
Methods
We analyzed baseline visit data of known carriers of a pathogenic variant in the c9orf72, GRN, or
MAPT gene from the Genetic Frontotemporal Dementia Initiative cohort study. Principal component
analysis with varimax rotation was performed to identify motor sign clusters that were
compared with respect to frequency and severity between groups. Associations with cross-sectional
atrophy patterns were determined using voxel-wise regression. We applied linear mixed effects
models to assess whether groups differed in the association between motor signs and estimated time
to symptom onset. Results
A total of 322 pathogenic variant carriers were included in the analysis: 122 c9orf72 (79 presymptomatic), 143 GRN (112
presymptomatic), and 57 MAPT (43 presymptomatic) pathogenic variant carriers. Principal component analysis revealed 5 motor
clusters, which we call progressive supranuclear palsy (PSP)-like, bulbar amyotrophic lateral sclerosis (ALS)-like, mixed/ALS-like,
Parkinson disease (PD) like, and corticobasal syndrome–like motor phenotypes. There was no significant group difference in the
frequency of signs of different motor phenotypes. However, mixed/ALS-like motor signs were most frequent, followed by PD-like
motor signs. Although the PSP-like phenotype was associated with mesencephalic atrophy, the mixed/ALS-like phenotype was
associated with motor cortex and corticospinal tract atrophy. The PD-like phenotype was associated with widespread cortical and
subcortical atrophy. Estimated time to onset, genetic group and their interaction influenced motor signs. In c9orf72 pathogenic
variant carriers, motor signs could be detected up to 25 years before expected symptom onset.
Discussion
These results indicate the presence of multiple natural clusters of motor signs in genetic FTD, each correlated with specific
atrophy patterns. Their motor severity depends on time and the affected gene. These clinicogenetic associations can guide
diagnostic evaluations and the design of clinical trials for new disease-modifying and preventive treatments.